Literature DB >> 15592510

Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis.

Masaaki Tatsuka1, Sunao Sato, Shojiro Kitajima, Shiho Suto, Hidehiko Kawai, Mutsumi Miyauchi, Ikuko Ogawa, Masayo Maeda, Takahide Ota, Takashi Takata.   

Abstract

Aurora kinases are known to play a key role in maintaining mitotic fidelity, and overexpression of aurora kinases has been noted in various tumors. Overexpression of aurora kinase activity is thought to promote cancer development through a loss of centrosome or chromosome number integrity. Here we observed augmentation of G12V-mutated HRAS-induced neoplastic transformation in BALB/c 3T3 A31-1-1 cells transfected with Aurora-A. Aurora-A-short hairpin RNA (shRNA) experiments showed that the expression level of Aurora-A determines susceptibility to transformation. Aurora-A gene amplification was noted in human patients with tongue or gingival squamous carcinoma (4/11). Amplification was observed even in pathologically normal epithelial tissue taken at sites distant from the tumors in two patients with tongue cancer. However, overexpression of Aurora-A mRNA was observed only within the tumors of all patients examined (11/11). Our data indicate that Aurora-A gene amplification and overexpression play a role in human carcinogenesis, largely due to the effect of Aurora-A on oncogenic cell growth, rather than a loss of maintenance of centrosomal or chromosomal integrity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15592510     DOI: 10.1038/sj.onc.1208293

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

Review 1.  Aurora kinases in head and neck cancer.

Authors:  Ranee Mehra; Ilya G Serebriiskii; Barbara Burtness; Igor Astsaturov; Erica A Golemis
Journal:  Lancet Oncol       Date:  2013-09       Impact factor: 41.316

2.  Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA.

Authors:  Kian-Huat Lim; Donita C Brady; David F Kashatus; Brooke B Ancrile; Channing J Der; Adrienne D Cox; Christopher M Counter
Journal:  Mol Cell Biol       Date:  2009-11-09       Impact factor: 4.272

3.  Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.

Authors:  Ami V Patel; David Eaves; Walter J Jessen; Tilat A Rizvi; Jeffrey A Ecsedy; Mark G Qian; Bruce J Aronow; John P Perentesis; Eduard Serra; Timothy P Cripe; Shyra J Miller; Nancy Ratner
Journal:  Clin Cancer Res       Date:  2012-07-18       Impact factor: 12.531

Review 4.  The potential role of Aurora kinase inhibitors in haematological malignancies.

Authors:  Sherif S Farag
Journal:  Br J Haematol       Date:  2011-10-08       Impact factor: 6.998

5.  Aurora A orchestrates entosis by regulating a dynamic MCAK-TIP150 interaction.

Authors:  Peng Xia; Jinhua Zhou; Xiaoyu Song; Bing Wu; Xing Liu; Di Li; Shuyuan Zhang; Zhikai Wang; Huijuan Yu; Tarsha Ward; Jiancun Zhang; Yinmei Li; Xiaoning Wang; Yong Chen; Zhen Guo; Xuebiao Yao
Journal:  J Mol Cell Biol       Date:  2014-05-20       Impact factor: 6.216

6.  Aurora-B regulates RNA methyltransferase NSUN2.

Authors:  Shiho Sakita-Suto; Akifumi Kanda; Fumio Suzuki; Sunao Sato; Takashi Takata; Masaaki Tatsuka
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

7.  Id1 overexpression induces tetraploidization and multiple abnormal mitotic phenotypes by modulating aurora A.

Authors:  Cornelia Man; Jack Rosa; Y L Yip; Annie Lai-Man Cheung; Y L Kwong; Stephen J Doxsey; S W Tsao
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

8.  RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.

Authors:  Gong Yang; Imelda Mercado-Uribe; Asha S Multani; Subrata Sen; Ie-Ming Shih; Kwong-Kwok Wong; David M Gershenson; Jinsong Liu
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

9.  Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.

Authors:  T-V Do; F Xiao; L E Bickel; A J Klein-Szanto; H B Pathak; X Hua; C Howe; S W O'Brien; M Maglaty; J A Ecsedy; S Litwin; E A Golemis; R J Schilder; A K Godwin; D C Connolly
Journal:  Oncogene       Date:  2013-01-21       Impact factor: 9.867

10.  Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.

Authors:  Ya-Shih Tseng; Jenq-Chang Lee; Chi-Ying F Huang; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2009-12-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.